Filing Overview
Issuer discrepancy: The provided Form 10-K is for Colfax Corporation, not Enovis Corporation. It covers the fiscal year ended December 31, 2011; fourth-quarter information is included in unaudited quarterly data.
Colfax was a global fluid-handling manufacturer serving commercial marine, oil and gas, power generation, defense and general industrial markets. The filing predates the January 13, 2012 acquisition of Charter International plc, which materially transformed the company into a broader gas-handling and fabrication-technology enterprise.
Financial Performance and Position
| Metric | 2011 | 2010 | Change |
|---|---|---|---|
| Net sales | $693.4 million | $542.0 million | +27.9% |
| Gross profit | $240.1 million | $191.4 million | +25.4% |
| Gross margin | 34.6% | 35.3% | Down 70 bps |
| Operating income | $25.9 million | $34.4 million | Down 24.6% |
| Operating margin | 3.7% | 6.3% | Down 260 bps |
| Net income | $4.6 million | $16.2 million | Down 71.9% |
| Diluted earnings per share | $0.10 | $0.37 | Down $0.27 |
| Cash flow from operations | $57.2 million | $62.0 million | Down $4.8 million |
| Cash and equivalents | $75.1 million | $60.5 million | Up $14.6 million |
| Total debt | $111.5 million | $82.5 million | Up $29.0 million |
Sales growth reflected higher demand across most end markets, acquisitions and favorable foreign-currency translation. Orders increased to $682.8 million from $532.8 million, while fluid-handling backlog increased to $347.2 million from $313.5 million. Approximately 90% of the year-end fluid-handling backlog was expected to ship during 2012, subject to postponement or cancellation.
Profitability was pressured by $31.1 million of Charter acquisition-related expense, higher selling, general and administrative costs, increased asbestos liability and defense costs, acquisition-related amortization and restructuring charges. The effective tax rate increased to 77.2% from 41.4%, primarily due to a $16.7 million increase in the valuation allowance.
Fourth-quarter 2011 net sales were $177.8 million, gross profit was $61.5 million and net loss was $16.1 million, including $25.3 million of pre-tax Charter acquisition-related expense.
Cash Flow, Debt and Liquidity
- Operating cash flow was $57.2 million. Capital expenditures were $14.8 million and acquisition spending, net of cash acquired, was $56.3 million.
- Net cash provided by financing activities was $32.7 million, principally reflecting net borrowings used to fund acquisitions.
- At December 31, 2011, debt consisted of $72.5 million under the term facility and $39.0 million under the revolving facility. Revolver availability was $92.1 million after outstanding letters of credit.
- The company stated that available liquidity, including the credit agreement, was adequate for the next twelve months.
- Subsequent to year-end, the Bank of America facility was replaced in connection with the Charter transaction by a Deutsche Bank facility consisting of $1.8 billion of term loans and $300 million of revolving commitments. Future interest expense was expected to increase materially.
- The new credit agreement included maximum total leverage and minimum interest coverage covenants, collateral pledges and restrictions on dividends, repurchases, additional debt, investments and asset dispositions.
Material Changes and Unusual Items
- Colfax completed the $2.6 billion Charter acquisition on January 13, 2012. Charter reported 2011 revenue of approximately £2.0 billion, with approximately 67% from ESAB and 33% from Howden.
- The transaction was financed with new debt, equity, preferred stock and cash. It resulted in substantial additional leverage, equity issuance and integration requirements.
- Colfax acquired Rosscor for $22.3 million in February 2011 and COT-Puritech for $39.4 million in December 2011, including estimated contingent consideration of $4.3 million.
- Restructuring charges were $9.7 million in 2011, with approximately $0.8 million of additional costs expected in 2012. Management expected approximately $4.1 million of annual pre-tax savings beginning in the first quarter of 2012, while also anticipating significant restructuring expense in the new fabrication-technology segment.
- Asbestos liabilities were $431.1 million and related insurance assets were $370.3 million at year-end. The estimated net undiscounted cash outlay over the next 15 years was $60.8 million, excluding potentially unestimable costs thereafter.
- The company had 23,682 unresolved asbestos claims at December 31, 2011. Insurance coverage litigation remained ongoing, and one subsidiary could have required funding of up to $10 million per quarter pending resolution.
- Acquisition-related foreign-exchange contracts had a $15.0 million liability at year-end and generated approximately $21.0 million of unrealized losses in 2011. The filing reports additional 2012 losses related to these contracts.
Outlook, Commentary and Risks
Management expected long-term organic growth from broader product offerings, expanded customer coverage and application of the Colfax Business System. Following Charter, the business mix was expected to be more balanced across long- and short-cycle markets, developed and emerging markets, and original-equipment and aftermarket activity.
Key execution priorities included integrating Charter, applying CBS to improve margins and working-capital management, rationalizing assets and back-office functions, consolidating manufacturing facilities and realizing expected synergies. No specific consolidated revenue or earnings guidance was provided.
- Principal risks included Charter integration failure, unanticipated liabilities, substantial leverage, restrictive debt covenants, higher interest expense and dilution from common and preferred stock issuance.
- Material contingencies included asbestos claims and insurance recoveries, product liability, environmental matters, government-contract compliance, pension underfunding and pending litigation.
- Approximately 70% of 2011 sales came from operations outside the United States, creating exposure to foreign-currency movements, political and economic conditions, sanctions, trade restrictions and regulatory compliance.
- Goodwill and intangible assets were substantial; management reported no impairment from its 2011 testing, but future underperformance or adverse market conditions could result in non-cash impairment charges.
- Management and Ernst & Young concluded that internal control over financial reporting was effective as of December 31, 2011, although controls at Rosscor and COT-Puritech were excluded from the assessment.
Investor Verification Items
- Confirm the issuer identity: the supplied filing is Colfax Corporation rather than Enovis Corporation.
- Reconcile the 2011 standalone results with the substantially larger post-acquisition Charter results and subsequent debt structure.
- Assess Charter integration progress, realized synergies, restructuring costs and the effect of higher interest expense on earnings and cash flow.
- Review leverage and interest-coverage compliance under the Deutsche Bank credit agreement, including covenant headroom and refinancing requirements.
- Evaluate the assumptions supporting the $431.1 million asbestos liability and $370.3 million insurance asset, including insurer solvency and pending coverage litigation.
- Review the effect of Charter-related foreign-exchange losses, equity dilution and the 6% cumulative dividend on Series A preferred stock.
- Verify the tax valuation allowance, deferred tax asset recoverability and utilization limits on approximately $135.3 million of U.S. net operating-loss carryforwards.